Aurora Cannabis sold a ton of weed last quarter. Nine metric tons, in fact.
Like the other Canadian pot producers reporting earnings Tuesday, Aurora increased sales strongly in its March quarter. Investors had worried that the recreational marijuana market was off to a slow start in Canada, but on Tuesday evening the Edmonton, Alberta-based Aurora Cannabis reported that its net revenue grew 20% from the December period, to reach 65 million Canadian dollars (or US$48.5 million) for the March period. Aurora’s recreational sales grew 37% sequentially.
“We achieved solid revenue growth and strong operating results in a quarter proven challenging across the industry,” Aurora’s chief executive Terry Booth said in the earnings announcement. The company will hold a conference call Wednesday at 10:30 a.m. E.T.
The dual-listed stock [ticker: ACB or ACB.Canada] was off 2.1% in after-hours trading, after it gained 4.5% Tuesday to close at $8.38 per share. Aurora Cannabis stock was down 2.7% in Wednesday morning trading, to $8.15 per share.
With most analysts rating the stock a Buy, Aurora stock has risen 70% this year to give it an $8 billion market capitalization. The average price target for the stock among analysts polled by FactSet is $10. [Read more at Barron’s]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
The process was like the slow burn of a fatty (prescribed for medicinal use only, of course). Last week, five years after Floridians voted to legalize medical marijuana in 2016, state officials announced an “emergency rule” that sets aside one medical marijuana license specifically for a Black farmer. That might seem like a welcome measure to help…
The federal farm bill in 2018 made the substance legal because of its low THC content. Three years after federal legislation removed the marijuana extract known as delta-8 THC from the nation’s list of controlled substances, Texas health officials have put it on its own list of illegal drugs, sending a shockwave through the growing…
The FDA’s failure to regulate a multibillion-dollar market is a detriment to consumers and businesses alike. In August of last year, the Food and Drug Administration held a teleconference with Sarah Brown, the proprietor of Maison Terre, a natural products repackager that Brown ran out of her home in Arkansas. An FDA lab analysis had…
In my 40 years of collecting a paycheck, I gotta admit this has been the oddest business trip I have ever embarked on, beginning with the packed Spirit Airline flight from Baltimore-Washington International Airport to the check-in at the Westgate hotel to grabbing my press credentials Tuesday afternoon at the Las Vegas Convention Center. When…